Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling

Citations Over TimeTop 10% of 2015 papers

Abstract

The activation of cancer-associated fibroblasts (CAFs) is a key event in tumor progression, and alternative extracellular matrix (ECM) proteins derived from CAFs induce ECM remodeling and cancer cell invasion. Here we found that miR-200 s, which are generally downregulated in activated CAFs in breast cancer tissues and in normal fibroblasts (NFs) activated by breast cancer cells, are direct mediators of NF reprogramming into CAFs and of ECM remodeling. NFs with downregulated miR-200 s displayed the traits of activated CAFs, including accelerated migration and invasion. Ectopic expression of miR-200 s in CAFs at least partially restored the phenotypes of NFs. CAF activation may be governed by the targets of miR-200 s, Fli-1 and TCF12, which are responsible for cell development and differentiation; Fli-1 and TCF12 were obviously elevated in CAFs. Furthermore, miR-200 s and their targets influenced collagen contraction by CAFs. The upregulation of fibronectin and lysyl oxidase directly by miR-200 or indirectly through Fli-1 or TCF12 contributed to ECM remodeling, triggering the invasion and metastasis of breast cancer cells both in vitro and vivo. Thus, these data provide important and novel insights into breast CAF activation and ECM remodeling, which trigger tumor cell invasion.

Related Papers

• → Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin(1996)139 cited
• → Fibroblast Migration on Fibronectin Requires Three Distinct Functional Domains(2003)111 cited
• → Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model(2020)4 cited
• → A fibronectin-related synthetic peptide, ProAlaSerSer, inhibits fibronectin binding to the cell surface, fibronectin-promoted cell migration in vitro, and cell migration in vivo(1990)30 cited
• → Extracellular Matrix Glycation and Crosslinking in Mammary Tumor Progression(2023)2 cited